{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T02:46:33Z","timestamp":1752461193121,"version":"3.40.5"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.atherosclerosis.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T14:15:32Z","timestamp":1507817732000},"page":"175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Interleukin-32 may contribute to increased risk of cardiovascular disease in patients with hidradenitis suppurativa"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1483-8440","authenticated-orcid":false,"given":"Valerio","family":"De Vita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.10.001_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2017.07.005","article-title":"Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases","volume":"264","author":"Damen","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.001_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2017.03.065","article-title":"Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction","volume":"243","author":"Xuan","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.001_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.15458","article-title":"Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa","author":"Thomi","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.atherosclerosis.2017.10.001_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of Major Adverse Cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.atherosclerosis.2017.10.001_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.114.03618","article-title":"Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis","volume":"65","author":"Wang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2017.10.001_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2013.09.017","article-title":"Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression","volume":"65","author":"Zeng","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2017.10.001_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2340\/00015555-1492","article-title":"Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa","volume":"93","author":"Mozeika","year":"2013","journal-title":"Acta Derm. Venereol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T22:00:23Z","timestamp":1535320823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":7,"alternative-id":["S0021915017313217"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.001","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-32 may contribute to increased risk of cardiovascular disease in patients with hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.07.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}